Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 ...

The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has announced a ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Siemens's share price has lost ground in the past few sessions following weak management commentary. The management indicated ...

There is no assurance that this process will result in the completion of any specific transaction or outcome. About Atea Pharmaceuticals Atea is a ... Any such forward-looking statements represent ...

Here we summarize some of the key challenges, critical success factors and key changes / change management ... process with multiple types of stakeholders with intertwined relationships ...

China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures ...

Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceutic ...

Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, ...

Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on January 2, 2025 (the “Grant Date”), ...

Jazz's neuroscience franchise faces declining Xyrem sales but sees growth in Xywav and Epidiolex. Oncology growth is driven ...